HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nelson L Michael Selected Research

GP 140

5/2022Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques.
1/2018Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
11/2016Lessons from HIV-1 vaccine efficacy trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nelson L Michael Research Topics

Disease

94Infections
01/2022 - 05/2003
33HIV Infections (HIV Infection)
01/2022 - 12/2009
14Disease Progression
10/2022 - 10/2002
13Viremia
10/2021 - 01/2014
9Vaccinia
05/2022 - 11/2010
9Inflammation (Inflammations)
10/2021 - 01/2016
7COVID-19
05/2022 - 01/2020
6Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2022 - 04/2010
6Acquired Immunodeficiency Syndrome (AIDS)
11/2020 - 02/2003
5Dengue (Dengue Fever)
01/2022 - 01/2015
4Zika Virus Infection
01/2021 - 08/2017
4Breakthrough Infections
01/2021 - 09/2012
4Virus Diseases (Viral Diseases)
01/2020 - 02/2002
2Bites and Stings (Sting)
10/2021 - 11/2017
2Communicable Diseases (Infectious Diseases)
01/2021 - 11/2018
2Pain (Aches)
01/2020 - 11/2017
2Persistent Infection
12/2018 - 01/2018
1Coinfection
01/2022
1Severe Acute Respiratory Syndrome
04/2021
1Belonephobia
01/2021
1Hearing Loss (Hearing Impairment)
01/2021
1Hepatitis B
01/2021
1Tick-Borne Encephalitis (Encephalitis, Tick Borne)
12/2020
1Yellow Fever
12/2020
1Japanese Encephalitis
12/2020
1Headache (Headaches)
01/2020
1Fatigue
01/2020
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
12/2019
1Fever (Fevers)
03/2019
1Encephalitis (Encephalitis, Rasmussen)
01/2018

Drug/Important Bio-Agent (IBA)

71VaccinesIBA
05/2022 - 10/2009
27AntibodiesIBA
01/2021 - 10/2009
16Proteins (Proteins, Gene)FDA Link
05/2022 - 02/2002
14RNA (Ribonucleic Acid)IBA
10/2021 - 06/2004
14Immunoglobulin G (IgG)IBA
01/2021 - 04/2012
13AntigensIBA
01/2022 - 06/2004
12AIDS VaccinesIBA
01/2021 - 04/2011
9Immunoglobulin A (IgA)IBA
12/2020 - 04/2012
8AIDSVAXIBA
11/2019 - 12/2009
7EpitopesIBA
10/2022 - 02/2011
7Neutralizing AntibodiesIBA
01/2022 - 01/2013
7DNA (Deoxyribonucleic Acid)IBA
11/2021 - 06/2007
7Glycoproteins (Glycoprotein)IBA
01/2021 - 12/2012
7Peptides (Polypeptides)IBA
11/2020 - 10/2009
7AIDSVAX B-EIBA
11/2019 - 12/2009
6Broadly Neutralizing AntibodiesIBA
01/2022 - 01/2017
6CytokinesIBA
01/2021 - 06/2014
5Biomarkers (Surrogate Marker)IBA
12/2020 - 05/2016
5Antiviral Agents (Antivirals)IBA
10/2019 - 10/2002
4Pharmaceutical PreparationsIBA
01/2020 - 01/2019
4Interleukin-6 (Interleukin 6)IBA
10/2019 - 04/2011
3HLA Antigens (Human Leukocyte Antigens)IBA
10/2022 - 11/2018
3GP 140IBA
05/2022 - 11/2016
3Indicators and Reagents (Reagents)IBA
01/2020 - 01/2014
3erdosteineIBA
11/2019 - 07/2012
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2018 - 01/2017
3ChemokinesIBA
01/2018 - 05/2009
3MF59 oil emulsionIBA
01/2018 - 02/2015
3Monoclonal AntibodiesIBA
02/2016 - 08/2015
2aluminum sulfate (alum)IBA
05/2022 - 02/2015
2COVID-19 VaccinesIBA
05/2022 - 09/2020
2NanovaccinesIBA
05/2022 - 03/2021
2Aluminum Hydroxide (Algeldrate)FDA Link
05/2022 - 02/2015
2Ferritins (Ferritin)IBA
05/2022 - 03/2021
2Polysaccharides (Glycans)IBA
10/2021 - 01/2016
2Complement System Proteins (Complement)IBA
01/2021 - 01/2017
2Fatty Acid-Binding ProteinsIBA
01/2017 - 05/2016
2Lipopolysaccharide ReceptorsIBA
01/2017 - 04/2011
2Liposomes (Liposome)IBA
01/2017 - 10/2009
2Nucleic AcidsIBA
06/2016 - 04/2015
1vesatolimodIBA
05/2022
1saponin QA-21V1 (QS21)IBA
05/2022
1Dihydrotachysterol (AT 10)IBA
01/2022
1Dengue VaccinesIBA
01/2022
1CYD-TDV vaccineIBA
01/2022
1Angiotensin-Converting Enzyme 2IBA
12/2021
1Viral RNAIBA
11/2021
1cyclic guanosine monophosphate-adenosine monophosphateIBA
10/2021
1SARS-CoV-2 spike proteinIBA
03/2021
1Illicit Drugs (Recreational Drugs)IBA
01/2021
1N 556IBA
01/2021
1tapasinIBA
11/2020
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
12/2019
11-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2019
1Interleukin-15 (Interleukin 15)IBA
12/2019
1NeopterinIBA
12/2019
1EnzymesIBA
03/2019
1ImmunosorbentsIBA
03/2019
1fas Receptor (CD95 Antigen)IBA
01/2019
1Mechanistic Target of Rapamycin Complex 1IBA
01/2019
1CD40 Ligand (CD40L)IBA
12/2018
1AluminumIBA
01/2018
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2018

Therapy/Procedure

14Therapeutics
01/2020 - 10/2002
10Art Therapy
10/2021 - 08/2014
4Highly Active Antiretroviral Therapy (HAART)
01/2017 - 05/2003
2Condoms (Condom)
01/2021 - 01/2019
2Aftercare (After-Treatment)
01/2016 - 01/2015
1Drug Therapy (Chemotherapy)
01/2022
1Intramuscular Injections
01/2018